TBX4mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension
Top Cited Papers
Open Access
- 16 April 2013
- journal article
- new disease-loci
- Published by BMJ in Journal of Medical Genetics
- Vol. 50 (8), 500-506
- https://doi.org/10.1136/jmedgenet-2012-101152
Abstract
Background Childhood-onset pulmonary arterial hypertension (PAH) is rare and differs from adult-onset disease in clinical presentation, with often unexplained mental retardation and dysmorphic features (MR/DF). Mutations in the major PAH gene, BMPR2, were reported to cause PAH in only 10–16% of childhood-onset patients. We aimed to identify more genes associated with childhood-onset PAH. Methods We studied 20 consecutive cases with idiopathic or heritable PAH. In patients with accompanying MR/DF (n=6) array-comparative genomic hybridisation analysis was performed, with the aim of finding common deletion regions containing candidate genes for PAH. Three patients had overlapping deletions of 17q23.2. TBX2 and TBX4 were selected from this area as candidate genes and sequenced in all 20 children. After identifying TBX4 mutations in these children, we subsequently sequenced TBX4 in a cohort of 49 adults with PAH. Because TBX4 mutations are known to cause small patella syndrome (SPS), all patients with newly detected TBX4 mutations were screened for features of SPS. We also screened a third cohort of 23 patients with SPS for PAH. Results TBX4 mutations (n=3) or TBX4-containing deletions (n=3) were detected in 6 out of 20 children with PAH (30%). All living patients and two parents with TBX4 mutations appeared to have previously unrecognised SPS. In the adult PAH-cohort, one TBX4 mutation (2%) was detected. Screening in the cohort of (predominantly adult) SPS patients revealed no PAH. Conclusions These data indicate that TBX4 mutations are associated with childhood-onset PAH, but that the prevalence of PAH in adult TBX4 mutation carriers is low.Keywords
This publication has 51 references indexed in Scilit:
- Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial HypertensionCirculation: Cardiovascular Genetics, 2012
- Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionHuman Mutation, 2011
- Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial HypertensionCirculation, 2010
- Basic Science of Pulmonary Arterial Hypertension for CliniciansCirculation, 2010
- Updated Clinical Classification of Pulmonary HypertensionJournal of the American College of Cardiology, 2009
- A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertensionJournal of Medical Genetics, 2009
- Clinical Implications of Determining BMPR2 Mutation Status in a Large Cohort of Children and Adults With Pulmonary Arterial HypertensionThe Journal of Heart and Lung Transplantation, 2008
- Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic TelangiectasiaThe New England Journal of Medicine, 2001
- Mutations in the TGF-beta type 1 receptor, ALK1, in combined primary pulmonary hypertension and hereditary haemorrhagic telangiectasia, implies pathway specificity.The Journal of Heart and Lung Transplantation, 2001
- Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertensionNature Genetics, 2000